Greenhouse Funds’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Greenhouse Funds’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-230,000	Closed	-$18.7M	–	41
2025 Q1	$18.7M	Sell	230,000 -20,000	-8%	-$1.79M	0.87%	32
2024 Q4	$22.5M	Buy	+250,000	New	+$24.2M	0.94%	33
2023 Q2	–	Sell	-50,000	Closed	-$3.81M	–	44
2023 Q1	$3.81M	Buy	+50,000	New	+$4.15M	0.32%	38

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Greenhouse Funds's XBI Position: Q1 2026 in Review

Greenhouse Funds reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.3% in Q1 2026, selling an estimated $4.57M and leaving 650,949 shares worth $83.1M. The position accounts for 3.72% of the portfolio, ranked #12.

Greenhouse Funds first reported a position in XBI in Q1 2025 and has held it in 5 quarters since. The position peaked at $83.8M in Q4 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Greenhouse Funds held 650,949 shares of State Street SPDR S&P Biotech ETF worth $83.1M as of Q1 2026.
Greenhouse Funds sold 36,575 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $4.57M.
State Street SPDR S&P Biotech ETF made up 3.72% of Greenhouse Funds's portfolio in Q1 2026, its #12 holding.
Greenhouse Funds first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 5 quarters since.
Greenhouse Funds's State Street SPDR S&P Biotech ETF position peaked at $83.8M in Q4 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Greenhouse Funds's 13F filing for Q1 2026, filed 15 May 2026.